CRIS Current Research Information System

FAROLFI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.777
NA - Nord America 1.904
EU - Europa 1.436
AF - Africa 153
SA - Sud America 148
OC - Oceania 2
Totale 6.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.864
VN - Vietnam 732
SG - Singapore 691
CN - Cina 688
IT - Italia 414
DE - Germania 260
HK - Hong Kong 242
SE - Svezia 165
GB - Regno Unito 135
IN - India 119
KR - Corea 101
BR - Brasile 97
FR - Francia 83
FI - Finlandia 81
RU - Federazione Russa 62
IE - Irlanda 55
CI - Costa d'Avorio 53
NL - Olanda 53
ZA - Sudafrica 31
JO - Giordania 30
JP - Giappone 30
TH - Thailandia 27
CA - Canada 26
PH - Filippine 23
BG - Bulgaria 22
TG - Togo 22
AR - Argentina 21
TR - Turchia 21
SC - Seychelles 19
AT - Austria 18
BD - Bangladesh 16
CH - Svizzera 14
UA - Ucraina 14
ID - Indonesia 13
PL - Polonia 12
BE - Belgio 11
MX - Messico 11
TW - Taiwan 11
IQ - Iraq 9
CO - Colombia 7
CL - Cile 6
EE - Estonia 6
PK - Pakistan 6
TN - Tunisia 6
EC - Ecuador 5
ES - Italia 5
NG - Nigeria 5
EG - Egitto 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BO - Bolivia 3
HR - Croazia 3
MA - Marocco 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
DK - Danimarca 2
DZ - Algeria 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
FJ - Figi 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MG - Madagascar 1
MT - Malta 1
MU - Mauritius 1
PF - Polinesia Francese 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
YT - Mayotte 1
Totale 6.420
Salva come PNG Salva come JPEG
Città #
Singapore 496
Ashburn 278
Hong Kong 224
Hefei 204
Ho Chi Minh City 170
Hanoi 132
Santa Clara 125
Chandler 122
San Jose 120
Fairfield 118
Munich 109
Southend 99
Seoul 95
Bologna 87
Helsinki 66
Beijing 65
Los Angeles 59
Dublin 54
Abidjan 53
Princeton 53
Woodbridge 52
Houston 50
Seattle 48
Dallas 45
Boardman 43
Wilmington 43
Dong Ket 40
Milan 40
Lauterbourg 39
New York 38
Cambridge 36
Amman 29
Ann Arbor 24
Haiphong 24
Tongling 24
Lomé 22
Buffalo 21
Da Nang 21
Bengaluru 20
Berlin 20
Nuremberg 20
Shanghai 19
Sofia 19
Tokyo 19
Guangzhou 18
Johannesburg 18
Turin 18
Redondo Beach 17
Rome 17
Florence 16
San Diego 15
Westminster 14
Council Bluffs 13
Orem 13
Redmond 13
Amsterdam 12
Des Moines 12
Bangkok 11
Brussels 11
Chicago 11
Istanbul 11
São Paulo 11
Bern 10
Montreal 10
Frankfurt am Main 9
London 9
Kuban 8
Mumbai 8
Phoenix 8
Vienna 8
Biên Hòa 7
Boydton 7
Can Tho 7
Changsha 7
Chennai 7
Jinan 7
Long Xuyen 7
Modena 7
Redwood City 7
Shijiazhuang 7
Thái Nguyên 7
Toronto 7
Warsaw 7
Yubileyny 7
Ankara 6
Bắc Giang 6
Bến Tre 6
Denver 6
Hyderabad 6
Hải Dương 6
Jakarta 6
Lappeenranta 6
Nanjing 6
Quận Bình Thạnh 6
Rio de Janeiro 6
Tianjin 6
Calderara Di Reno 5
Casalecchio di Reno 5
Forlì 5
Ha Long 5
Totale 3.996
Salva come PNG Salva come JPEG
Nome #
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 304
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence 269
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 257
Adult patients with intellectual disability and epilepsy: clinical and genetic study of 114 cases 247
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 221
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 218
Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach 213
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. 203
FDG-PET assessment and metabolic patterns in Lafora disease 189
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection 182
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient 181
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 180
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer. 167
A step towards a multidisciplinary interpretative algorithm for indeterminate adrenal lesions: the value of visual and semi-quantitative 18F-FDG PET/CT and ceCT parameters 158
[68Ga]Ga-PSMA-11 PET/CT-Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging. 156
Pictorial essay: normal variants, lesions, and pitfalls in Ga-68-PSMA PET imaging of prostate cancer. 156
68 Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer After Prostatectomy in a Multicenter Retrospective Study 156
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL. 155
Incidental finding of [68Ga]Ga-PSMA-avid intraductal papillary mucinous neoplasm 154
Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series. 143
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis 137
FDG-PET/CT Guided Biopsy in Angiosarcoma of Bone: Diagnosis, Staging and Beyond. 137
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET. 134
Single Subcutaneous Prostate Cancer Metastasis Detected by 68 Ga-PSMA PET/CT During Early Biochemical Relapse: A Case Report 133
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions 128
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study. 128
Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis. 124
Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease 119
Plasma androgen receptor in prostate cancer 118
Evaluating [68Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study. 114
null 113
Molecular Imaging and Theranostics-A Multidisciplinary Approach 109
The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis 108
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity 106
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy 106
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence 100
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more? 89
Highlights From 2017: Impactful Topics Published in the Annals of Nuclear Medicine 89
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget. 85
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology 82
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial 79
Non-oncologic incidental uptake on FAPI PET/CT imaging 65
PET imaging in urology: a rapidly growing successful collaboration. 58
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review. 58
Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients 50
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 50
Refining prognostic stratification in salvage radiotherapy for prostate cancer: a retrospective multicenter cohort study using PSMA-PET and machine learning 20
Totale 6.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 13 7 82
2021/2022610 102 18 21 59 41 26 16 46 35 33 141 72
2022/2023638 45 79 34 46 54 49 31 57 129 14 62 38
2023/2024318 25 39 26 20 28 80 12 16 23 18 20 11
2024/20251.436 76 119 113 89 177 79 142 77 71 87 115 291
2025/20262.923 331 416 266 253 267 155 393 100 559 183 0 0
Totale 6.548